Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-03-24
DOI
https://doi.org/10.1001/jamanetworkopen.2025.1689
Citations
2
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
2.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes

Niels Jongs, Hiddo J.L. Heerspink, Jelle M. Beernink, C. J. A. Doelman et al.
2 citations
JAMA Network Open
Diabetes Treatment and Management
2.59
article

Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes

Niels Jongs, Hiddo J.L. Heerspink, Jelle M. Beernink, C. J. A. Doelman, Gozewijn D. Laverman
article en
2 citations

Abstract

No abstract available for this paper.
JAMA Network OpenVol. 8(3)
University Medical Center Groningen (NL), Ziekenhuis Groep Twente (NL), University of Twente (NL)
AstraZeneca, Sanofi, Alexion Pharmaceuticals, CSL Behring, Novo Nordisk, Universitair Medisch Centrum Groningen, Idorsia Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 11%
Diabetes Treatment and Management
2.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.